GREY:ATBPF - Post by User
Post by
Benedict16thon Feb 18, 2021 5:33am
263 Views
Post# 32593135
Short term pain for long term gains
Short term pain for long term gains Going to the NASDAQ is a double edge sword i.e. in a positions of weakness "not enough cash" is not a good idea as the cowboys will punish you with naked short selling knowing that the company will need to raise the cash to proceed with phase 3. Now when listed on the Nasdaq investor will only focus in ATE potentials only. Further ATE does not have to sell further geographical licencing rights to anyone on the cheap as it was alluded on this board by some posters. In all it is a necessary and painful but a good strategy to move forward while undertrain offer from big pharma without financial need and stress. Further it is easier to sell ATE with no further deal for geographical area. Big pharma do not like that. My 2 cents.